What is Cytely?
Cytely operates at the intersection of deep technology and biomedical research, specializing in Smart Microscopy. This innovative approach converts traditional imaging processes into a source of quantitative, actionable data, thereby accelerating the pace of discovery in the life sciences. The company's technology is designed to provide researchers and developers with unprecedented insights from their imaging data, facilitating faster and more accurate breakthroughs.
How much funding has Cytely raised?
Cytely has raised a total of $3.5M across 1 funding round:
Unspecified
$3.5M
Unspecified (2025): $3.5M with participation from Ugly Duckling Ventures and Icebreaker.vc
Key Investors in Cytely
Ugly Duckling Ventures
Ugly Duckling Ventures is a venture capital firm that provides capital and expertise to seed and pre-seed stage Nordic ventures, with a focus on early-stage B2B subscription startups that demonstrate strong commercial traction and recurring revenue.
Icebreaker.vc
Icebreaker.vc is a venture capital firm and community dedicated to building strong tech companies, investing in very early-stage Nordic & Baltic software-driven companies with strong founder teams.
What's next for Cytely?
With the recent major strategic investment and substantial overall capital, Cytely is poised for significant expansion and further technological development. This infusion of capital will likely fuel advancements in their Smart Microscopy platform, enabling broader adoption across the biomedical research community. The company's focus on transforming imaging into quantitative data positions it as a key player in the future of drug discovery and diagnostic development, suggesting a trajectory towards scaling operations and solidifying its market presence.
See full Cytely company page
